The move could help shape federal rules and ultimately lower prices for Vermonters.
We hear a lot about how the middle class has stagnated, or even shrunk, over the past 40 years — but that’s not the whole story.
News Release -- Rep. Peter Welch Jan. 14, 2019 Contact: Kate Hamilton (Welch) (202) 440-3340 Chris Berardi (Rooney) (202) 897-7700 Welch, Rooney Demand Regulator Scrutiny of $74 Billion Celgene, Bristol-Meyers Squibb Merger WASHINGTON – Reps. Peter Welch (D-Vt.) and Francis Rooney (R-Fla.) sent a letter late Friday to federal regulators demanding scrutiny of the impact […]
News Release -- Rep. Peter Welch, Sen. Bernie Sanders October 25, 2017 Contact: Kate Hamilton (Welch) -- [email protected] Josh Miller-Lewis (Sanders) -- [email protected] WASHNGTON – Rep. Peter Welch (D-VT), Sen. Bernie Sanders (I-VT) and Reps. Elijah Cummings (D-MD) and Lloyd Doggett (D-TX) today introduced legislation to require the federal government to leverage its bulk purchasing […]
News Release -- Sen. Patrick Leahy July 20, 2017 Contact: David Carle (202) 224-3693 Taylor Foy (202) 224-5225 Kirsten Hartman (202) 224-3244 Conn Carroll (202) 224-5444 Leahy And Bipartisan Drug Affordability Cosponsors Urge FDA Commissioner To Reform Anticompetitive Drug Practices WASHINGTON (THURSDAY, July 20, 2017) – U.S. Senator Patrick Leahy (D-Vt.), joined by Senators Chuck […]
A House committee refused to let Americans buy cheaper prescription drugs in Canada. But the Vermont Democrat says there are signs Congress may be waking up to the problem of high prices.
News Release -- Rep. Peter Welch April 7, 2017 Contact: Kirsten Hartman, Communications Director (202) 225-4115 Welch, McKinley Introduce Bipartisan Bill to Increase Consumer Access, Drive Down Costs, and Boost Market Competition for Generic Pharmaceuticals WASHINGTON—Rep. Peter Welch (D-VT) and Rep. David McKinley (R-WV)this week introduced the Fair Access for Safe and Timely (FAST) Generics […]
The Senate Health and Welfare Committee has endorsed a bill designed to allow doctors who go to conferences to eat meals paid for by pharmaceutical companies. The committee voted 5-0 in favor of S.45. The bill now heads to the Senate floor. S.45 updates an existing Vermont law that requires pharmaceutical companies to disclose gifts […]
Lawmakers say the landmark price transparency law passed in 2016 is not getting the results they sought.
The pharmaceutical company has increased the price of a lifesaving drug injector more than sixfold over the last two years.
Rep. Peter Welch, D-Vt., has introduced legislation to stop pharmaceutical companies from being able to exploit the so-called orphan drug loophole.
U.S. Rep. Peter Welch, D-Vt., has announced that the House Oversight and Government Reform Committee will hold a hearing on prescription drug prices. The hearing will be Wednesday, according to a news release from Welch’s office. The announcement comes less than a week after Welch and a colleague wrote a letter to the committee chair […]
News Release — Rep. Peter Welch Sept. 9, 2016 Contact: Kirsten Hartman, Communications Director (202) 225-4115 Rep. Peter Welch's letter to Oversight and Government Reform Committee Chairman Jason Chaffetz In light of recent intolerable and inexplicable price increases in the lifesaving EpiPen, Welch and Rep. Tammy Duckworth (D-IL) this afternoon requested that the Committee hold […]
Patient needs must be on par with shareholder profits as a matter of public policy.